Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02588664 · ClinicalTrials.gov registry record · NA

Comprehensive Post-Acute Stroke Services

A NA study of Stroke and Transient Ischemic Attack, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
6,024
Enrollment target
20
Study locations

NCT02588664 is a NA study of Stroke and Transient Ischemic Attack that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6,024 participants, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02588664, a NA study of Stroke and Transient Ischemic Attack, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
6,024 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduces caregiver stress, and reduces readmission rates.

Interventions

  • OTHER COMPASS Intervention

Study Locations (20)

North Carolina

  • CHS Stanly - Albemarle
  • Mission Hospital - Asheville
  • UNC Hospital - Chapel Hill
  • CHS Carolinas Medical Center - Charlotte
  • Novant Health Presbyterian Medical Center - Charlotte
  • CHS Carolinas Medical Center-Mercy - Charlotte
  • CHS University - Charlotte
  • CHS Northeast - Concord
  • Betsy Johnson Hospital - Dunn
  • Morehead Memorial Hospital - Eden
  • Hugh Chatham Memorial Hospital - Elkin
  • Cape Fear Valley Medical Center - Fayetteville
  • Angel Medical Center - Franklin
  • Pardee Health - Hendersonville
  • Frye Regional Medical Center - Hickory
  • Novant Health Huntersville - Huntersville
  • Onslow Memorial Hospital - Jacksonville
  • Ashe Memorial Hospital - Jefferson
  • Vidant Duplin Hospital - Kenansville
  • CHS Kings Mountain - Kings Mountain

Trial Details

FieldValue
Enrollment Target 6,024 participants
Start Date 2016-07-25
Est. Completion 2020-03-15
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02588664

The ClinicalTrials.gov registry entry for NCT02588664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,024 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which COMPASS Intervention is the first listed.

NCT02588664 reports 20 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02588664 about?

NCT02588664 is a clinical study titled "Comprehensive Post-Acute Stroke Services". The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduce...

What is the current status of trial NCT02588664?

This trial is currently completed. It is a NA study. The enrollment target is 6,024 participants. The study started on 2016-07-25. Estimated completion is 2020-03-15.

What conditions does trial NCT02588664 study?

This clinical trial studies the following conditions: Stroke, Transient Ischemic Attack.

What interventions are being tested in trial NCT02588664?

The interventions under investigation include: COMPASS Intervention (OTHER).

Who is sponsoring clinical trial NCT02588664?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02588664 being conducted?

This trial has 20 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.